Literature DB >> 33752691

Circadian clock: a regulator of the immunity in cancer.

Zhen Zhang1,2, Puhua Zeng3, Wenhui Gao2, Qing Zhou4, Ting Feng1,2, Xuefei Tian5,6.   

Abstract

The circadian clock is an endogenous timekeeper system that controls and optimizes biological processes, which are consistent with a master circadian clock and peripheral clocks and are controlled by various genes. Notably, the disruption of circadian clock genes has been identified to affect a wide range of ailments, including cancers. The cancer-immunity cycle is composed of seven major steps, namely cancer cell antigen release and presentation, priming and activation of effector immunity cells, trafficking, and infiltration of immunity to tumors, and elimination of cancer cells. Existing evidence indicates that the circadian clock functions as a gate that govern many aspects of the cancer-immunity cycle. In this review, we highlight the importance of the circadian clock during tumorigenesis, and discuss the potential role of the circadian clock in the cancer-immunity cycle. A comprehensive understanding of the regulatory function of the circadian clock in the cancer-immunity cycle holds promise in developing new strategies for the treatment of cancer. Video Abstract.

Entities:  

Keywords:  Cancer; Cancer-immunity cycle; Chrono-immunotherapies; Circadian clock; Tumor microenvironment (TME)

Mesh:

Year:  2021        PMID: 33752691      PMCID: PMC7986390          DOI: 10.1186/s12964-021-00721-2

Source DB:  PubMed          Journal:  Cell Commun Signal        ISSN: 1478-811X            Impact factor:   5.712


  121 in total

1.  Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats.

Authors:  Ryan W Logan; Changqing Zhang; Sengottuvelan Murugan; Stephanie O'Connell; Dale Levitt; Alan M Rosenwasser; Dipak K Sarkar
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

2.  Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.

Authors:  Beatriz M Carreno; Vincent Magrini; Michelle Becker-Hapak; Saghar Kaabinejadian; Jasreet Hundal; Allegra A Petti; Amy Ly; Wen-Rong Lie; William H Hildebrand; Elaine R Mardis; Gerald P Linette
Journal:  Science       Date:  2015-04-02       Impact factor: 47.728

3.  Pretreatment body mass index and clinical outcomes in cancer patients following immune checkpoint inhibitors: a systematic review and meta-analysis.

Authors:  Haizhu Chen; Daquan Wang; Qiaofeng Zhong; Yunxia Tao; Yu Zhou; Yuankai Shi
Journal:  Cancer Immunol Immunother       Date:  2020-08-04       Impact factor: 6.968

4.  Characterization of the core mammalian clock component, NPAS2, as a REV-ERBalpha/RORalpha target gene.

Authors:  Christine Crumbley; Yongjun Wang; Douglas J Kojetin; Thomas P Burris
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

5.  Increased breast cancer risk among women who work predominantly at night.

Authors:  J Hansen
Journal:  Epidemiology       Date:  2001-01       Impact factor: 4.822

Review 6.  A matter of time: study of circadian clocks and their role in inflammation.

Authors:  Stuart J Carter; Hannah J Durrington; Julie E Gibbs; John Blaikley; Andrew S Loudon; David W Ray; Ian Sabroe
Journal:  J Leukoc Biol       Date:  2016-02-08       Impact factor: 4.962

7.  Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.

Authors:  Matthew M Gubin; Xiuli Zhang; Heiko Schuster; Etienne Caron; Jeffrey P Ward; Takuro Noguchi; Yulia Ivanova; Jasreet Hundal; Cora D Arthur; Willem-Jan Krebber; Gwenn E Mulder; Mireille Toebes; Matthew D Vesely; Samuel S K Lam; Alan J Korman; James P Allison; Gordon J Freeman; Arlene H Sharpe; Erika L Pearce; Ton N Schumacher; Ruedi Aebersold; Hans-Georg Rammensee; Cornelis J M Melief; Elaine R Mardis; William E Gillanders; Maxim N Artyomov; Robert D Schreiber
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

8.  Glucose-Raising Polymorphisms in the Human Clock Gene Cryptochrome 2 (CRY2) Affect Hepatic Lipid Content.

Authors:  Fausto Machicao; Andreas Peter; Jürgen Machann; Ingmar Königsrainer; Anja Böhm; Stefan Zoltan Lutz; Martin Heni; Andreas Fritsche; Fritz Schick; Alfred Königsrainer; Norbert Stefan; Hans-Ulrich Häring; Harald Staiger
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

9.  Expression of the Circadian Clock Gene BMAL1 Positively Correlates With Antitumor Immunity and Patient Survival in Metastatic Melanoma.

Authors:  Leonardo Vinícius Monteiro de Assis; Gabriela Sarti Kinker; Maria Nathália Moraes; Regina P Markus; Pedro Augusto Fernandes; Ana Maria de Lauro Castrucci
Journal:  Front Oncol       Date:  2018-06-12       Impact factor: 6.244

10.  Circadian clock associates with tumor microenvironment in thoracic cancers.

Authors:  Yong Yang; Guangda Yuan; Hongya Xie; Tengteng Wei; Donglin Zhu; Jianyong Cui; Xiaoqiang Liu; Rongming Shen; Yimeng Zhu; Xuefang Yang
Journal:  Aging (Albany NY)       Date:  2019-12-23       Impact factor: 5.682

View more
  10 in total

Review 1.  Circadian Rhythms, Disease and Chronotherapy.

Authors:  Yool Lee; Jeffrey M Field; Amita Sehgal
Journal:  J Biol Rhythms       Date:  2021-09-22       Impact factor: 3.649

Review 2.  Strategies for Remodeling the Tumor Microenvironment Using Active Ingredients of Ginseng-A Promising Approach for Cancer Therapy.

Authors:  Mo Li; Xin Wang; Ying Wang; Shunchao Bao; Qing Chang; Linlin Liu; Shuai Zhang; Liwei Sun
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

3.  Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer.

Authors:  Abdoulaye Karaboué; Thierry Collon; Ida Pavese; Viviane Bodiguel; Joel Cucherousset; Elda Zakine; Pasquale F Innominato; Mohamed Bouchahda; René Adam; Francis Lévi
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

4.  Analysis of Tumor Glycosylation Characteristics and Implications for Immune Checkpoint Inhibitor's Efficacy for Breast Cancer.

Authors:  Wenchang Lv; Honghao Yu; Mei Han; Yufang Tan; Min Wu; Jun Zhang; Yiping Wu; Qi Zhang
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

5.  Genome-wide CRISPR Screening Reveals Pyrimidine Metabolic Reprogramming in 5-FU Chronochemotherapy of Colorectal Cancer.

Authors:  Ya Niu; Xinyi Fan; Yaping Wang; Jiaxin Lin; Luchun Hua; Xiaobo Li; Ruizhe Qian; Chao Lu
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

6.  Identification of circadian clock genes as regulators of immune infiltration in Hepatocellular Carcinoma.

Authors:  Zhen Zhang; Zicheng Liang; Wenhui Gao; Shuxian Yu; Zongwei Hou; Kexin Li; Puhua Zeng
Journal:  J Cancer       Date:  2022-09-01       Impact factor: 4.478

7.  Insomnia in patients treated with checkpoint inhibitors for cancer: A meta-analysis.

Authors:  Igor Kiss; Matyas Kuhn; Kristian Hrusak; Benjamin Buchler; Ludmila Boublikova; Tomas Buchler
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

8.  Stress hormone signalling inhibits Th1 polarization in a CD4 T-cell-intrinsic manner via mTORC1 and the circadian gene PER1.

Authors:  Christophe M Capelle; Anna Chen; Ni Zeng; Alexandre Baron; Kamil Grzyb; Thais Arns; Alexander Skupin; Markus Ollert; Feng Q Hefeng
Journal:  Immunology       Date:  2022-03-02       Impact factor: 7.215

9.  Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.

Authors:  Aoxiao He; Zhihao Huang; Rongguiyi Zhang; Hongcheng Lu; Jiakun Wang; Jiaqing Cao; Qian Feng
Journal:  Comput Math Methods Med       Date:  2022-01-25       Impact factor: 2.238

10.  Development and validation of prognostic model based on the analysis of autophagy-related genes in colon cancer.

Authors:  Yongfeng Wang; Kaili Lin; Tianchun Xu; Liuli Wang; Liangyin Fu; Guangming Zhang; Jing Ai; Yajun Jiao; Rongrong Zhu; Xiaoyong Han; Hui Cai
Journal:  Aging (Albany NY)       Date:  2021-07-27       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.